Ligand Pharmaceuticals, Inc. (LGND)
286.85
-0.09
(-0.03%)
USD |
NASDAQ |
Nov 20, 16:00
286.93
+0.08
(+0.03%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Return Level : 381.71 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 381.71 |
| November 19, 2026 | 381.83 |
| November 18, 2026 | 397.49 |
| November 17, 2026 | 390.97 |
| November 16, 2026 | 401.48 |
| November 13, 2026 | 410.90 |
| November 12, 2026 | 420.86 |
| November 11, 2026 | 421.60 |
| November 10, 2026 | 418.05 |
| November 09, 2026 | 418.04 |
| November 06, 2026 | 407.46 |
| November 05, 2026 | 397.88 |
| November 04, 2026 | 420.67 |
| November 03, 2026 | 417.20 |
| November 02, 2026 | 408.55 |
| October 30, 2026 | 429.48 |
| October 29, 2026 | 422.27 |
| October 28, 2026 | 424.20 |
| October 27, 2026 | 414.82 |
| October 26, 2026 | 410.25 |
| October 23, 2026 | 403.90 |
| October 22, 2026 | 409.61 |
| October 21, 2026 | 418.87 |
| October 20, 2026 | 407.72 |
| October 19, 2026 | 395.59 |
| Date | Value |
|---|---|
| October 16, 2026 | 393.27 |
| October 15, 2026 | 397.21 |
| October 14, 2026 | 392.54 |
| October 13, 2026 | 403.90 |
| October 12, 2026 | 414.02 |
| October 09, 2026 | 401.61 |
| October 08, 2026 | 392.55 |
| October 07, 2026 | 390.24 |
| October 06, 2026 | 395.13 |
| October 05, 2026 | 408.22 |
| October 02, 2026 | 403.15 |
| October 01, 2026 | 402.85 |
| September 30, 2026 | 415.67 |
| September 29, 2026 | 412.99 |
| September 28, 2026 | 417.97 |
| September 25, 2026 | 401.23 |
| September 24, 2026 | 397.93 |
| September 23, 2026 | 397.09 |
| September 22, 2026 | 397.21 |
| September 21, 2026 | 385.99 |
| September 18, 2026 | 377.24 |
| September 17, 2026 | 378.85 |
| September 16, 2026 | 366.21 |
| September 15, 2026 | 368.57 |
| September 14, 2026 | 373.46 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Johnson & Johnson | 645.40 |
| Eli Lilly & Co. | 3563.61 |
| Bristol Myers Squibb Co. | 224.76 |
| Xeris Biopharma Holdings, Inc. | 16.97 |
| LENZ Therapeutics, Inc. | 3.154 |